← Alle mensen

MA

Mehmet Ali Nahit Şendur

4 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Totale overleving with Amivantamab-Lazertinib in EGFR-Mutated Gevorderd NSCLC.

The New England journal of medicine · 30 oktober 2025

Efficacy and safety of eerstelijns maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-...

Lancet (London, England) · 14 juni 2025

The Phase 3 KEYLYNK-006 Study of Pembrolizumab Plus Olaparib Versus Pembrolizumab Plus Pemetrexed as Maintenance Ther...

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2025-02

Subcutaan versus IV amivantamab plus lazertinib bij EGFR-gemuteerd NSCLC: PALOMA-3

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 oktober 2024